QQQ   303.81 (-0.77%)
AAPL   152.16 (-1.51%)
MSFT   256.11 (-0.87%)
META   187.13 (+0.32%)
GOOGL   102.54 (-2.14%)
AMZN   102.25 (-1.10%)
TSLA   194.16 (+2.20%)
NVDA   211.03 (+0.01%)
NIO   10.83 (-3.22%)
BABA   105.73 (-0.56%)
AMD   83.54 (-2.96%)
T   19.59 (-1.21%)
F   12.97 (-1.97%)
MU   60.01 (-3.85%)
CGC   2.92 (+0.00%)
GE   82.02 (+0.07%)
DIS   109.27 (-1.30%)
AMC   6.43 (+5.76%)
PFE   43.90 (-0.36%)
PYPL   82.85 (-3.12%)
NFLX   364.65 (-0.34%)
QQQ   303.81 (-0.77%)
AAPL   152.16 (-1.51%)
MSFT   256.11 (-0.87%)
META   187.13 (+0.32%)
GOOGL   102.54 (-2.14%)
AMZN   102.25 (-1.10%)
TSLA   194.16 (+2.20%)
NVDA   211.03 (+0.01%)
NIO   10.83 (-3.22%)
BABA   105.73 (-0.56%)
AMD   83.54 (-2.96%)
T   19.59 (-1.21%)
F   12.97 (-1.97%)
MU   60.01 (-3.85%)
CGC   2.92 (+0.00%)
GE   82.02 (+0.07%)
DIS   109.27 (-1.30%)
AMC   6.43 (+5.76%)
PFE   43.90 (-0.36%)
PYPL   82.85 (-3.12%)
NFLX   364.65 (-0.34%)
QQQ   303.81 (-0.77%)
AAPL   152.16 (-1.51%)
MSFT   256.11 (-0.87%)
META   187.13 (+0.32%)
GOOGL   102.54 (-2.14%)
AMZN   102.25 (-1.10%)
TSLA   194.16 (+2.20%)
NVDA   211.03 (+0.01%)
NIO   10.83 (-3.22%)
BABA   105.73 (-0.56%)
AMD   83.54 (-2.96%)
T   19.59 (-1.21%)
F   12.97 (-1.97%)
MU   60.01 (-3.85%)
CGC   2.92 (+0.00%)
GE   82.02 (+0.07%)
DIS   109.27 (-1.30%)
AMC   6.43 (+5.76%)
PFE   43.90 (-0.36%)
PYPL   82.85 (-3.12%)
NFLX   364.65 (-0.34%)
QQQ   303.81 (-0.77%)
AAPL   152.16 (-1.51%)
MSFT   256.11 (-0.87%)
META   187.13 (+0.32%)
GOOGL   102.54 (-2.14%)
AMZN   102.25 (-1.10%)
TSLA   194.16 (+2.20%)
NVDA   211.03 (+0.01%)
NIO   10.83 (-3.22%)
BABA   105.73 (-0.56%)
AMD   83.54 (-2.96%)
T   19.59 (-1.21%)
F   12.97 (-1.97%)
MU   60.01 (-3.85%)
CGC   2.92 (+0.00%)
GE   82.02 (+0.07%)
DIS   109.27 (-1.30%)
AMC   6.43 (+5.76%)
PFE   43.90 (-0.36%)
PYPL   82.85 (-3.12%)
NFLX   364.65 (-0.34%)
NASDAQ:PDEX

Pro-Dex - PDEX Stock Forecast, Price & News

$16.58
-0.13 (-0.78%)
(As of 02/6/2023 01:47 PM ET)
Add
Compare
Today's Range
$16.57
▼
$16.62
50-Day Range
$15.80
▼
$17.80
52-Week Range
$12.40
▼
$23.20
Volume
4,088 shs
Average Volume
6,538 shs
Market Capitalization
$58.69 million
P/E Ratio
16.10
Dividend Yield
N/A
Price Target
$30.00

Pro-Dex MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
80.9% Upside
$30.00 Price Target
Short Interest
Healthy
0.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.11mentions of Pro-Dex in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Medical Sector

848th out of 1,027 stocks

Surgical & Medical Instruments Industry

91st out of 105 stocks

See Top Rated MarketRank™ Stocks Here
PDEX stock logo

About Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

February 2, 2023 | msn.com
Pro-Dex GAAP EPS of $0.24 misses by $0.05, revenue of $11.28M beats by $0.88M
February 2, 2023 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
February 6, 2023 | Wall Street Watch Dogs (Ad)
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
February 2, 2023 | americanbankingnews.com
Pro-Dex (NASDAQ:PDEX) Now Covered by Analysts at StockNews.com
January 30, 2023 | seekingalpha.com
Pro-Dex Is Growing But Expensive Given Its Risk
January 20, 2023 | finance.yahoo.com
Why Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth Watching
January 18, 2023 | reuters.com
PDEX.A - | Stock Price & Latest News | Reuters
December 21, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 19% CAGR over the last five years
February 6, 2023 | Wall Street Watch Dogs (Ad)
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
November 25, 2022 | msn.com
Pro-Dex Earnings Perspective: Return On Invested Capital
November 23, 2022 | finance.yahoo.com
Declining Stock and Solid Fundamentals: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)?
November 9, 2022 | finance.yahoo.com
Pro-Dex First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
November 4, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results
October 22, 2022 | finance.yahoo.com
Quite a few insiders invested in Pro-Dex, Inc. (NASDAQ:PDEX) last year which is positive news for shareholders
October 17, 2022 | nasdaq.com
Pro-Dex (NASDAQ:PDEX) May Have Issues Allocating Its Capital
September 29, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses Record-Breaking 4th Quarter Results and Year-Over-Year Growth with The Stock Day Podcast
September 26, 2022 | seekingalpha.com
Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
September 20, 2022 | finance.yahoo.com
Some Investors May Be Worried About Pro-Dex's (NASDAQ:PDEX) Returns On Capital
August 25, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2022 Fourth Quarter And Full-Year Results
August 6, 2022 | reuters.com
Pro-Dex Inc
July 31, 2022 | nasdaq.com
Here's Why Pro-Dex (NASDAQ:PDEX) Has A Meaningful Debt Burden
July 14, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 21% CAGR over the last five years
June 14, 2022 | finance.yahoo.com
Pro-Dex, Inc. (NASDAQ:PDEX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
June 6, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses 2022 Goals and Third Quarter Results with The Stock Day Podcast
May 15, 2022 | finance.yahoo.com
A number of insiders bought Pro-Dex, Inc. (NASDAQ:PDEX) stock last year, which is great news for shareholders
May 12, 2022 | seekingalpha.com
PDEX and DPSI among mid-day movers
May 5, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2022 Third Quarter and Nine-Month Results
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Company Calendar

Last Earnings
11/15/2021
Today
2/06/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
6/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PDEX
CUSIP
N/A
CIK
788920
Web
www.pro-dex.com
Phone
(949) 769-3200
Fax
949-769-3281
Employees
117
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+80.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.03
Trailing P/E Ratio
16.10
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.86 million
Net Margins
8.64%
Pretax Margin
10.38%
Return on Equity
16.12%
Return on Assets
8.19%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
2.69
Quick Ratio
1.39

Sales & Book Value

Annual Sales
$42.04 million
Price / Sales
1.40
Cash Flow
$1.28 per share
Price / Cash Flow
12.94
Book Value
$6.54 per share
Price / Book
2.54

Miscellaneous

Outstanding Shares
3,540,000
Free Float
2,034,000
Market Cap
$58.69 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Richard Lee van Kirk
    President, Chief Executive Officer, COO & Director
  • Alisha K. CharltonAlisha K. Charlton
    Chief Financial Officer & Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions













PDEX Stock - Frequently Asked Questions

What is Pro-Dex's stock price forecast for 2023?

0 brokerages have issued 12-month target prices for Pro-Dex's stock. Their PDEX share price forecasts range from $30.00 to $30.00. On average, they predict the company's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 79.5% from the stock's current price.
View analysts price targets for PDEX or view top-rated stocks among Wall Street analysts.

How have PDEX shares performed in 2023?

Pro-Dex's stock was trading at $15.90 at the beginning of 2023. Since then, PDEX shares have increased by 5.1% and is now trading at $16.71.
View the best growth stocks for 2023 here.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our PDEX earnings forecast.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its quarterly earnings results on Monday, November, 15th. The medical instruments supplier reported $0.28 earnings per share for the quarter, meeting the consensus estimate of $0.28. The medical instruments supplier had revenue of $9.99 million for the quarter. Pro-Dex had a net margin of 8.64% and a trailing twelve-month return on equity of 16.30%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $16.71.

How much money does Pro-Dex make?

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $59.82 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.03 on an earnings per share basis.

How many employees does Pro-Dex have?

The company employs 117 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.

This page (NASDAQ:PDEX) was last updated on 2/6/2023 by MarketBeat.com Staff